论文部分内容阅读
Objectives Previous studies showed improvement in heart function by injecting bone marrow mesenchymal stem cells (BMSCs) after AMI.Emerging evidence suggested that both the number and function of BMSCs decline with ageing.We designed a randomised, controlled trial to further investigate the safety and efficacy of this treatment.